H. Worth (Fuerth, Germany), P. Chanez (Montpellier, France)
The effect of oxygen treatment on oxidant/antioxidant balance in acute exacerbations of COPD
Z. Orhan, N. Koksal, M. Gokirmak, S. Hacievliyagil, C. Hasanoglu, N. Mehmet, Z. Yildirim (Malatya, Turkey)
|  |
Effect of angiotensin II receptor antagonists on cardiovascular disorders in patients with COPD
R. R. Frangulyan (Yerevan, Armenia)
| |
Definition of risk development obstructive syndrome with patients chronic bronchitis (CB)
L. N. Karlova, T. V. Ivtchik, A. N. Kokosov, E. A. Kiseleva, G. I. Rasorenov, T. S. Rasorenova, E. D. Iantchina (Saint-Petersburg, Russia)
| |
Activity of the cells of APUD system- is a factor exerting influence on the development of emphysema and pneumosclerosis
A. Z. Kuzmin, V. I. Trofimov (Samara, Saint-Petersburg, Russia)
| |
Respiratory oxalosis (RO) as a hereditary form of COPD
G. Pospekhova, V. Vakharlovsky, V. Antonov, A. Karpischenko, O. Voronina (Saint-Petersburg, Russia)
| |
Chronic cough as a diagnostic problem
J. Stojkovic, T. Caparoska, G. Breskovska, G. Stevcevska, K. Busjletic (Skopje, Macedonia)
| |
Forced expiratory volume in one second (FEV1) and peak expiratory flow (PEF): is there a correlation in chronic obstructive pulmonary disease (COPD) patients?
P. Monteiro, A. B. de Almeida (Lisbon, Portugal)
| |
Changes in patients perception of dyspnoea, sputum volume and sputum purulence during treatment of chronic bronchitis exacerbations
Z. Z. Pavlovic-Popovic, Z. Zoricic-Major, M. Krivokapic, V. Pupavac, Z. Markovic (Sremska Kamenica, Yugoslavia)
| |
Cross-sectional study to evaluate the role of exacerbations in COPD progression
B. Cynowska, R. K. Ucinska, L. Wolska-Goszka, K. Kuziemski, J. M. Slominski, I. Damps, M. Porzezinska (Gdansk, Poland)
| |
Serum sex hormone levels in COPD patients and its relation with hypoxaemia and pulmonary functions
F. Karadag, A. Karul, M. Polatli, M. Cam, O. Cildag (Aydin, Turkey)
| |
Analysis of parameters of lung function in patients with severe chronic obstructive pulmonary disease
S. Radulovic, I. Stankovic, T. Pejcic, J. Dukic, D. Djordjevic (Nis, Yugoslavia)
| |
Heredity and smoking factor in relatives patients with chronic obstructive pulmonary disease - chronic obstructive bronchitis (I) and chronic nonobstructive bronchitis (II)
T. V. Ivtchik, G. I. Rasorenov, A. N. Kokosov, E. A. Kiseleva, N. E. Hodgaynce, L. N. Karlova, E. D. Iantchina, V. P. Molodtsova, N. G. Yakovleva, V. V. Lim (Saint-Petersburg, Russia)
| |
Oxygenotherapy and life duration
P. K. Yablonsky, A. V. Nefedov, N. E. Okuneva, T. A. Fedorova, T. A. Stepanenko (Saint-Petersburg, Russia)
| |
Comparison of oral prednisolone and nebulized budesonide in the treatment of acute exacerbations of COPD
D. Djordjevic, I. Stankovic, D. Zivkovic, T. Pejcic, S. Radulovic (Nis, Yugoslavia)
| |
Cytokine-induced mechanisms of osteopenic syndrome in the chronic obstructive pulmonary disease (COPD)
E. A. Kochetkova, B. I. Geltser, T. N. Sourovenko, M. V. Volkova, E. E. Peteshova (Vladivostok, Russia)
| |
Relationship between body mass index (BMI), tumour-necrosis factor-alpha (TNFα) and bone density in chronic obstructive pulmonary disease (COPD)
E. A. Kochetkova, M. V. Volkova, B. I. Geltser (Vladivostok, Russia)
| |
The effect of anti-oxidant therapy on pulmonary functions and arterial blood gases in COPD
I. Keskinel, T. Demir, A. Aydemir, E. Serdaroglu, N. Yildirim, B. Sahin (Istanbul, Turkey)
| |
Syndromology of bronchopulmonary system damage for the COPD-patients after liquidation of consequences of Chernobyl catastrophe
V. A. Sushko (Kiev, Ukraine)
| |
The effect of methylxanthine, corticosteroid, and N -acetylcystein on plasma oxidant/antioxidant levels in patients with COPD
A. Kocabas, I. Hanta, S. Kuleci, G. Seydaoglu (Adana, Turkey)
| |